LeMaitre Vascular
LMAT
147 hedge funds and large institutions have $446M invested in LeMaitre Vascular in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 13 closing their positions.
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
6% more capital invested
Capital invested by funds: $420M → $446M (+$26M)
2% more funds holding
Funds holding: 144 → 147 (+3)
8% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 49
0.45% less ownership
Funds ownership: 84.06% → 83.61% (-0.45%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$4.19M |
| 2 |
TCM
Tygh Capital Management
Portland,
Oregon
|
+$3.4M |
| 3 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$3.25M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$3.03M |
| 5 |
Morgan Stanley
New York
|
+$2.43M |
Top Sellers
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$4.35M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$3.61M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.89M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.87M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.8M |
LMAT Hedge Fund Activity: Q2 2020 in Review
147 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2020, worth a combined $446M — up 6.2% from $420M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new LMAT positions and 13 closed out — a net gain of 4 holders — while 53 added to existing stakes and 49 trimmed.
The largest buyer was BlackRock, adding an estimated $4.19M. The largest seller was Ranger Investment Management, cutting an estimated $4.35M.
- 147 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2020, up from 144 in Q1 2020.
- Funds reported $446M of LeMaitre Vascular stock for Q2 2020, up 6.2% quarter-over-quarter.
- 17 funds opened new LeMaitre Vascular positions in Q2 2020 and 13 closed out, a net change of +4 holders.
- The largest LeMaitre Vascular buyer in Q2 2020 was BlackRock, an estimated $4.19M added.
- The largest LeMaitre Vascular seller in Q2 2020 was Ranger Investment Management, an estimated $4.35M sold.
Based on aggregated 13F filings for Q2 2020.